Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Cancers
|
December 17, 2024
Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor
Sandra Cantilena, Mohamed AlAmeri, Noelia Che, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy
Elvira Crescenzi, Giuseppe Palumbo, Jasper de Boer, et al.
Cancer Medicine
|
March 8, 2022
Optimising the quality of multidisciplinary team meetings: A narrative review
Thanh Hai Tran, Jasper de Boer, David E Gyorki, et al.
The Journal of Biological Chemistry
|
December 29, 2005
Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis
John G Clohessy, Jianguo Zhuang, Jasper de Boer, et al.
Nature Communications
|
December 3, 2024
Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay
Ursula Saade, Jasper de Boer, Ivan Scandale, et al.
Blood
|
June 7, 2013
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia
Maurizio Mangolini, Jasper de Boer, Vanessa Walf-Vorderwülbecke, et al.
Plos One
|
September 29, 2022
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects
Jasper de Boer, Ursula Saade, Elodie Granjon, et al.
Experimental Hematology & Oncology
|
August 16, 2024
Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes
Noelia Che, Sandra Cantilena, Remi Looi-Somoye, et al.
Blood
|
November 26, 2008
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities
Sarah J Horton, Vanessa Walf-Vorderwülbecke, Steve J Chatters, et al.
Blood
|
October 18, 2012
Frat2 mediates the oncogenic activation of Rac by MLL fusions
Vanessa Walf-Vorderwülbecke, Jasper de Boer, Sarah J Horton, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Cancers
|
December 17, 2024
Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor
Sandra Cantilena, Mohamed AlAmeri, Noelia Che, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy
Elvira Crescenzi, Giuseppe Palumbo, Jasper de Boer, et al.
Cancer Medicine
|
March 8, 2022
Optimising the quality of multidisciplinary team meetings: A narrative review
Thanh Hai Tran, Jasper de Boer, David E Gyorki, et al.
The Journal of Biological Chemistry
|
December 29, 2005
Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis
John G Clohessy, Jianguo Zhuang, Jasper de Boer, et al.
Nature Communications
|
December 3, 2024
Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay
Ursula Saade, Jasper de Boer, Ivan Scandale, et al.
Blood
|
June 7, 2013
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia
Maurizio Mangolini, Jasper de Boer, Vanessa Walf-Vorderwülbecke, et al.
Plos One
|
September 29, 2022
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects
Jasper de Boer, Ursula Saade, Elodie Granjon, et al.
Experimental Hematology & Oncology
|
August 16, 2024
Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes
Noelia Che, Sandra Cantilena, Remi Looi-Somoye, et al.
Blood
|
November 26, 2008
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities
Sarah J Horton, Vanessa Walf-Vorderwülbecke, Steve J Chatters, et al.
Blood
|
October 18, 2012
Frat2 mediates the oncogenic activation of Rac by MLL fusions
Vanessa Walf-Vorderwülbecke, Jasper de Boer, Sarah J Horton, et al.
Page
of 4